Fludarabine plus cyclophosphamide (FC) and dose intensified chlorambucil (DIC) for the treatment of chronic lymphocytic leukemia (CLL): Results of two phase II studies (CLL2-protocol) of the german cll study group (GCLLSG).

M Hallek; Martin Wilhelm; B Emmerich; H Dohner; HP Fostitsch; O Sezer; M Herold; W Knauf; R Busch; B Schmitt; CM Wendtner; R Kuse; M Freund; A Franke; F Schriever; C Nerl; E Thiel; W Hiddemann; G Brittinger

Fludarabine plus cyclophosphamide (FC) and dose intensified chlorambucil (DIC) for the treatment of chronic lymphocytic leukemia (CLL): Results of two phase II studies (CLL2-protocol) of the german cll study group (GCLLSG).

M Hallek
, Martin Wilhelm
, B Emmerich
, H Dohner
, HP Fostitsch
, O Sezer
, M Herold
, W Knauf
, R Busch
, B Schmitt
, CM Wendtner
, R Kuse
, M Freund
, A Franke
, F Schriever
, C Nerl
, E Thiel
, W Hiddemann
, G Brittinger

Universitätsklinik für Innere Medizin 5 - Onkologie und Hämatologie

Publikation: Beitrag in Fachzeitschrift › Abstrakt (Zeitschrift) › Begutachtung

5 Quellenangaben (Web of Science)

Originalsprache	Englisch
Seiten (von - bis)	313A-313A
Fachzeitschrift	BLOOD
Jahrgang	94
Ausgabenummer	10
Publikationsstatus	Veröffentlicht - 1999

Dieses zitieren

Hallek, M., Wilhelm, M., Emmerich, B., Dohner, H., Fostitsch, HP., Sezer, O., Herold, M., Knauf, W., Busch, R., Schmitt, B., Wendtner, CM., Kuse, R., Freund, M., Franke, A., Schriever, F., Nerl, C., Thiel, E., Hiddemann, W., & Brittinger, G. (1999). Fludarabine plus cyclophosphamide (FC) and dose intensified chlorambucil (DIC) for the treatment of chronic lymphocytic leukemia (CLL): Results of two phase II studies (CLL2-protocol) of the german cll study group (GCLLSG). BLOOD , 94(10), 313A-313A.

Hallek, M ; Wilhelm, Martin ; Emmerich, B et al. / Fludarabine plus cyclophosphamide (FC) and dose intensified chlorambucil (DIC) for the treatment of chronic lymphocytic leukemia (CLL): Results of two phase II studies (CLL2-protocol) of the german cll study group (GCLLSG). in: BLOOD 1999 ; Jahrgang 94, Nr. 10. S. 313A-313A.

@article{55940652acd54ad8b97aae3b8ea0fb2f,

title = "Fludarabine plus cyclophosphamide (FC) and dose intensified chlorambucil (DIC) for the treatment of chronic lymphocytic leukemia (CLL): Results of two phase II studies (CLL2-protocol) of the german cll study group (GCLLSG).",

author = "M Hallek and Martin Wilhelm and B Emmerich and H Dohner and HP Fostitsch and O Sezer and M Herold and W Knauf and R Busch and B Schmitt and CM Wendtner and R Kuse and M Freund and A Franke and F Schriever and C Nerl and E Thiel and W Hiddemann and G Brittinger",

year = "1999",

language = "English",

volume = "94",

pages = "313A--313A",

journal = "BLOOD ",

issn = "0006-4971",

publisher = "American Society of Hematology ",

number = "10",

}

Hallek, M, Wilhelm, M, Emmerich, B, Dohner, H, Fostitsch, HP, Sezer, O, Herold, M, Knauf, W, Busch, R, Schmitt, B, Wendtner, CM, Kuse, R, Freund, M, Franke, A, Schriever, F, Nerl, C, Thiel, E, Hiddemann, W & Brittinger, G 1999, 'Fludarabine plus cyclophosphamide (FC) and dose intensified chlorambucil (DIC) for the treatment of chronic lymphocytic leukemia (CLL): Results of two phase II studies (CLL2-protocol) of the german cll study group (GCLLSG).', BLOOD , Jg. 94, Nr. 10, S. 313A-313A.

Fludarabine plus cyclophosphamide (FC) and dose intensified chlorambucil (DIC) for the treatment of chronic lymphocytic leukemia (CLL): Results of two phase II studies (CLL2-protocol) of the german cll study group (GCLLSG). / Hallek, M; Wilhelm, Martin; Emmerich, B et al.
in: BLOOD , Jahrgang 94, Nr. 10, 1999, S. 313A-313A.

Publikation: Beitrag in Fachzeitschrift › Abstrakt (Zeitschrift) › Begutachtung

TY - JOUR

T1 - Fludarabine plus cyclophosphamide (FC) and dose intensified chlorambucil (DIC) for the treatment of chronic lymphocytic leukemia (CLL): Results of two phase II studies (CLL2-protocol) of the german cll study group (GCLLSG).

AU - Hallek, M

AU - Wilhelm, Martin

AU - Emmerich, B

AU - Dohner, H

AU - Fostitsch, HP

AU - Sezer, O

AU - Herold, M

AU - Knauf, W

AU - Busch, R

AU - Schmitt, B

AU - Wendtner, CM

AU - Kuse, R

AU - Freund, M

AU - Franke, A

AU - Schriever, F

AU - Nerl, C

AU - Thiel, E

AU - Hiddemann, W

AU - Brittinger, G

PY - 1999

Y1 - 1999

M3 - Abstract (Journal)

SN - 0006-4971

VL - 94

SP - 313A-313A

JO - BLOOD

JF - BLOOD

IS - 10

ER -

Hallek M, Wilhelm M, Emmerich B, Dohner H, Fostitsch HP, Sezer O et al. Fludarabine plus cyclophosphamide (FC) and dose intensified chlorambucil (DIC) for the treatment of chronic lymphocytic leukemia (CLL): Results of two phase II studies (CLL2-protocol) of the german cll study group (GCLLSG). BLOOD . 1999;94(10):313A-313A.